▁The 10.375
▁study 10.625
▁was 2.783203125
▁conducted 2.712890625
▁in 1.6923828125
▁the 2.00390625
▁form 3.859375
▁of 0.2357177734375
▁collection 9.375
▁and 2.95703125
▁analysis 3.5078125
▁of 1.0537109375
▁statistical 6.82421875
▁data 3.138671875
. 1.669921875
▁Part 5.890625
icip 0.2100830078125
ants 0.472412109375
▁were 1.552734375
▁rec 4.1875
ru 0.0008978843688964844
ited 0.00018107891082763672
▁for 3.40625
▁six 7.36328125
▁months 0.94677734375
▁at 4.15625
▁two 3.240234375
▁major 4.8515625
▁pain 9.140625
▁relief 4.63671875
▁cent 1.580078125
ers 0.446044921875
▁in 0.7431640625
▁Israel 3.859375
. 0.66064453125
▁The 1.7001953125
▁research 4.359375
ers 1.146484375
▁used 3.099609375
▁The 7.5390625
▁De 7.71484375
pression 1.1826171875
▁Module 7.0546875
▁of 1.169921875
▁the 0.415283203125
▁Pat 3.19140625
ient 0.01062774658203125
▁Health 0.171142578125
▁Question 0.10003662109375
naire 0.0222930908203125
▁and 3.349609375
▁the 0.970703125
▁General 3.462890625
ized 0.6240234375
▁An 0.1287841796875
x 0.0024394989013671875
iety 0.0070648193359375
▁Dis 0.83740234375
order 0.03924560546875
▁Sc 2.013671875
ale 0.06732177734375
▁to 1.736328125
▁interview 7.546875
▁participants 2.05078125
, 3.501953125
▁evaluate 6.51171875
▁their 1.162109375
▁answers 6.4296875
, 0.80615234375
▁and 0.1317138671875
▁conduct 4.54296875
▁the 1.93359375
▁study 1.3974609375
. 0.201416015625
▁To 5.3203125
▁specifically 9.8203125
▁evaluate 2.06640625
▁and 3.845703125
▁compare 1.931640625
▁the 0.548828125
▁prob 10.5625
abilities 1.8359375
▁of 0.244873046875
▁de 2.22265625
pression 0.10894775390625
▁or 4.3359375
▁anx 0.1602783203125
iety 0.0006041526794433594
▁among 3.1953125
▁the 1.5712890625
▁diverse 8.6015625
▁groups 2.251953125
, 1.375
▁the 1.0791015625
▁study 3.005859375
▁used 1.65234375
▁multiple 4.5703125
▁log 2.095703125
istic 0.0662841796875
▁regression 0.1275634765625
▁analysis 0.64208984375
▁and 2.654296875
▁chose 8.9921875
▁medical 8.46875
▁mar 7.59765625
iju 0.02752685546875
ana 6.80685043334961e-05
▁as 1.376953125
▁the 0.61376953125
▁control 2.46875
▁group 0.74560546875
. 0.331787109375
<0x0A> 1.810546875
There 4.90625
▁is 2.37890625
▁currently 4.12890625
▁a 1.53515625
▁severe 5.37890625
▁lack 2.482421875
▁of 0.0299530029296875
▁information 2.30078125
▁about 1.54296875
▁the 0.65478515625
▁effects 2.65625
▁of 0.09234619140625
▁op 8.3359375
i 2.822265625
ates 0.0214996337890625
. 4.2578125
▁They 5.765625
▁manage 8.7734375
▁pain 2.0703125
▁successfully 5.99609375
, 1.1826171875
▁but 0.416748046875
▁the 2.591796875
▁past 9.5390625
▁few 1.8076171875
▁dec 0.74560546875
ades 6.532669067382812e-05
▁indicated 10.2109375
▁the 2.591796875
▁growing 4.6015625
▁concern 3.470703125
▁regarding 3.0546875
▁op 3.119140625
iate 0.38330078125
▁ab 1.5439453125
use 0.006961822509765625
▁in 3.46484375
▁forms 10.640625
▁of 0.5654296875
▁over 3.71875
d 0.433837890625
ose 0.15771484375
▁and 0.77734375
▁add 1.013671875
iction 0.02423095703125
. 0.1954345703125
▁A 4.14453125
▁more 5.58203125
▁manage 8.328125
able 0.0018224716186523438
▁and 1.95703125
▁sa 2.041015625
fer 7.486343383789062e-05
▁alternative 1.08203125
▁might 5.64453125
▁be 0.304443359375
▁medical 2.44921875
▁mar 0.149658203125
iju 0.0017633438110351562
ana 0.0004391670227050781
. 0.74755859375
▁However 3.6484375
, 0.006931304931640625
▁the 1.544921875
▁legal 3.94921875
▁status 1.087890625
▁and 2.669921875
▁novel 9.546875
ty 0.73974609375
▁of 0.1815185546875
▁this 1.755859375
▁drug 2.220703125
▁do 5.55078125
▁not 0.14404296875
▁allow 1.044921875
▁finding 9.3671875
▁a 2.068359375
▁large 4.0
▁number 1.763671875
▁of 0.007602691650390625
▁studies 1.322265625
▁on 1.8603515625
▁its 1.0771484375
▁effect 1.8466796875
iveness 0.32666015625
. 1.1318359375
▁Specifically 7.5703125
, 0.145263671875
▁it 3.45703125
▁concerns 6.7109375
▁the 0.6875
▁emot 8.0234375
ional 0.0183563232421875
▁condition 5.16796875
▁of 0.68701171875
▁patients 1.0048828125
▁experien 6.3984375
cing 5.996227264404297e-05
▁chron 1.6474609375
ic 0.000820159912109375
▁pain 0.1514892578125
. 0.7060546875
▁This 3.005859375
▁research 3.203125
▁paper 5.46484375
▁a 1.974609375
ims 0.00026726722717285156
▁to 0.10467529296875
▁analyze 2.998046875
▁levels 10.59375
▁of 0.0531005859375
▁de 0.4091796875
pression 0.02685546875
▁and 0.31982421875
▁anx 0.04827880859375
iety 0.0006504058837890625
▁among 1.0078125
▁people 3.853515625
▁receiving 3.798828125
▁ther 6.2265625
apy 0.08056640625
▁by 4.734375
▁comparing 5.20703125
▁the 1.427734375
▁effects 2.953125
▁of 0.09710693359375
▁ph 7.5625
arma 0.4423828125
ce 0.0009102821350097656
ut 7.545948028564453e-05
ical 0.007171630859375
▁op 1.4443359375
io 1.962890625
ids 0.326416015625
▁and 1.0966796875
▁MM 7.859375
. 7.22265625
<0x0A> 1.359375
Chr 6.4140625
onic 0.032867431640625
▁pain 0.1986083984375
▁is 0.73681640625
▁still 6.20703125
▁considered 2.2890625
▁to 2.384765625
▁be 0.0283660888671875
▁an 2.578125
▁extreme 5.83984375
▁issue 4.3125
▁among 3.294921875
▁at 9.6953125
▁least 0.29541015625
▁ 0.55859375
8 2.693359375
% 3.865234375
▁of 0.0606689453125
▁the 0.3603515625
▁residents 8.171875
▁of 0.84912109375
▁progress 13.65625
ive 0.46142578125
▁countries 0.962890625
. 0.61328125
▁The 2.0390625
▁introduction 6.453125
▁of 0.0614013671875
▁the 2.671875
▁study 5.13671875
▁describes 7.66015625
▁the 0.76123046875
▁apparent 8.921875
▁link 4.578125
▁between 0.1309814453125
▁pain 3.2578125
▁and 0.417236328125
▁dem 9.9375
oral 1.9267578125
ization 0.156494140625
. 1.0166015625
▁Chron 4.84375
ic 0.0053863525390625
▁pain 0.106201171875
▁is 1.2646484375
▁always 6.00390625
▁accompanied 1.09375
▁by 0.07275390625
▁negative 3.841796875
▁emot 0.82958984375
ional 1.5263671875
▁experiences 3.6484375
▁and 2.310546875
▁blocks 9.953125
▁a 3.58984375
▁person 0.62255859375
’ 26.640625
s 1.923828125
▁ability 1.1455078125
▁to 0.0214996337890625
▁receive 6.0546875
▁joy 4.671875
▁and 1.2421875
▁satisfaction 2.919921875
▁from 1.2421875
▁life 0.89794921875
. 0.1796875
▁The 1.69921875
▁research 2.75
▁investig 4.26171875
ates 0.261474609375
▁the 0.44482421875
▁development 7.0
▁of 0.1650390625
▁de 1.2333984375
pression 0.11260986328125
▁and 0.351806640625
▁anx 0.116455078125
iety 0.0014696121215820312
▁among 1.203125
▁patients 1.044921875
▁receiving 1.36328125
▁ph 3.43359375
arma 0.107421875
ce 0.0012378692626953125
ut 6.389617919921875e-05
ical 0.0029392242431640625
▁op 0.4912109375
io 0.061492919921875
ids 0.108154296875
▁and 0.716796875
▁medical 1.2109375
▁mar 0.120849609375
iju 0.005970001220703125
ana 0.00015866756439208984
▁( 3.73046875
MM 0.099365234375
) 1.0888671875
▁as 1.3662109375
▁severe 11.0234375
▁pain 2.720703125
kill 4.359375
ers 0.0004203319549560547
. 0.51171875
▁It 3.10546875
▁comp 4.12109375
ares 0.019622802734375
▁the 0.42236328125
▁effic 5.64453125
acy 0.004974365234375
▁of 0.22265625
▁pres 4.8828125
cri 1.9697265625
ptions 0.42529296875
▁and 1.6171875
▁exam 5.015625
ines 0.0194091796875
▁the 0.47509765625
▁possibility 3.890625
▁of 0.10345458984375
▁post 7.4765625
- 0.66748046875
tre 1.3896484375
at 0.0005517005920410156
ment 0.0026683807373046875
▁de 2.673828125
pression 0.05029296875
. 2.076171875
<0x0A> 0.83056640625
The 1.138671875
▁question 6.55859375
na 3.46875
ires 0.00078582763671875
▁used 1.9677734375
▁different 9.15625
▁variable 8.9765625
▁measures 3.677734375
▁to 1.318359375
▁collect 2.537109375
▁information 2.03515625
. 2.255859375
▁For 3.765625
▁example 0.908203125
, 0.0274658203125
▁it 4.375
▁included 3.005859375
▁compreh 9.3046875
ensive 0.0268402099609375
▁so 7.04296875
cio 0.0364990234375
- 0.387939453125
dem 0.089599609375
ographic 0.045379638671875
▁data 1.220703125
: 5.9296875
▁gender 1.6572265625
, 0.10748291015625
▁age 0.2218017578125
, 0.09332275390625
▁country 4.54296875
, 1.37890625
▁type 3.7890625
▁of 0.057830810546875
▁residence 4.73828125
▁( 3.1796875
urban 1.880859375
/ 2.744140625
r 0.0615234375
ural 0.0007257461547851562
), 0.390380859375
▁years 5.65234375
▁of 0.1793212890625
▁education 1.0361328125
, 0.284423828125
▁and 1.9462890625
▁employ 3.5
ment 0.00408935546875
▁status 0.392822265625
. 0.2261962890625
▁Pat 4.51953125
ients 0.1734619140625
▁were 1.189453125
▁also 1.5771484375
▁asked 0.689453125
▁about 1.021484375
▁their 0.64306640625
▁medical 2.623046875
▁history 0.33642578125
▁over 8.921875
▁the 0.1580810546875
▁years 3.556640625
▁and 1.9814453125
▁the 2.025390625
▁current 3.65625
▁presence 5.7890625
▁of 0.057830810546875
▁any 2.64453125
▁severe 5.61328125
▁dise 2.197265625
ases 0.00011169910430908203
▁such 3.8046875
▁as 0.0063629150390625
▁heart 2.1953125
▁failure 2.484375
, 0.17138671875
▁di 1.7392578125
ab 0.0021076202392578125
etes 0.003940582275390625
, 0.2073974609375
▁ar 3.671875
th 0.09033203125
rit 0.0362548828125
is 0.0114288330078125
, 0.1080322265625
▁and 1.759765625
▁so 3.16796875
▁on 0.1546630859375
. 0.034454345703125
▁The 1.81640625
▁third 6.546875
▁measure 4.34765625
▁of 2.26171875
▁the 0.8515625
▁question 3.0078125
naire 0.04510498046875
▁was 0.80419921875
▁indicated 9.84375
▁by 1.0166015625
▁information 6.1640625
▁on 1.5791015625
▁any 5.296875
▁twelve 13.6484375
- 1.19140625
month 0.380126953125
▁and 6.07421875
▁lifetime 3.23828125
▁drug 5.0546875
▁and 3.271484375
▁alco 0.0634765625
hol 7.891654968261719e-05
▁consumption 2.767578125
. 0.5322265625
▁In 3.498046875
▁addition 0.72021484375
, 0.10650634765625
▁the 1.2412109375
▁record 7.8515625
▁included 2.173828125
▁a 2.71875
▁pain 6.44140625
▁measurement 4.22265625
▁scale 1.04296875
▁from 3.6171875
▁ 0.5634765625
0 0.41357421875
▁to 0.416015625
▁ 0.007904052734375
1 0.0914306640625
0 0.063720703125
▁to 4.5390625
▁evaluate 1.9580078125
▁dis 6.55859375
com 0.2198486328125
fort 0.0007557868957519531
▁feelings 7.17578125
▁during 3.1796875
▁the 0.66845703125
▁last 1.734375
▁month 1.619140625
. 0.30126953125
<0x0A> 1.142578125
This 3.55078125
▁type 5.60546875
▁of 0.0218963623046875
▁study 1.8330078125
▁is 1.8515625
▁the 3.1171875
▁most 2.8125
▁reve 8.6953125
aling 0.001033782958984375
▁and 1.33203125
▁inclus 6.53125
ive 0.0027980804443359375
, 2.900390625
▁as 1.927734375
▁it 0.3759765625
▁contains 4.609375
▁direct 6.49609375
▁responses 5.79296875
▁from 0.8896484375
▁a 3.96875
▁large 1.16796875
▁number 0.48046875
▁of 0.00444793701171875
▁participants 1.71875
. 0.6962890625
▁All 4.21484375
▁tools 9.265625
▁in 5.14453125
▁the 0.66357421875
▁form 2.09375
▁of 0.110107421875
▁question 4.6796875
na 0.340576171875
ires 0.00016677379608154297
▁and 0.798828125
▁scales 3.384765625
▁have 4.12890625
▁already 4.3203125
▁been 0.1339111328125
▁used 1.794921875
▁and 2.767578125
▁proved 4.765625
▁their 1.8115234375
▁effic 3.453125
acy 0.00017714500427246094
▁for 3.232421875
▁collect 3.55859375
ing 0.007171630859375
▁analyt 8.3125
ical 0.256103515625
▁data 0.402099609375
. 0.58837890625
▁It 3.880859375
▁helps 4.93359375
▁to 0.921875
▁system 7.390625
at 1.3134765625
ize 0.00893402099609375
▁and 1.724609375
▁class 4.0078125
ify 0.003509521484375
▁distinct 9.2109375
▁kinds 5.9921875
▁of 0.0199737548828125
▁information 2.974609375
▁for 3.76953125
▁subsequent 4.375
▁un 7.89453125
comp 5.41796875
licated 0.07293701171875
▁services 11.5234375
. 0.70361328125
▁Thus 4.40625
, 0.03155517578125
▁research 4.578125
ers 0.45849609375
▁can 1.5830078125
▁compare 3.765625
▁the 1.068359375
▁effects 3.0390625
▁of 0.1005859375
▁medic 4.4375
ations 0.9580078125
▁on 1.9599609375
▁patients 2.134765625
▁of 4.453125
▁diverse 3.955078125
▁age 2.380859375
▁groups 0.8212890625
, 0.8203125
▁background 4.75
s 0.252685546875
, 0.0706787109375
▁physical 5.7109375
▁conditions 1.4267578125
, 0.08038330078125
▁emot 5.3671875
ional 0.0885009765625
▁states 1.2724609375
, 0.09942626953125
▁and 0.436279296875
▁so 1.998046875
▁on 0.10009765625
. 0.0987548828125
<0x0A> 0.98486328125
The 1.0712890625
▁study 1.953125
▁conducted 4.359375
▁a 2.20703125
▁correlation 5.76953125
▁type 7.1015625
▁of 0.30078125
▁research 1.84765625
▁with 2.83203125
▁variable 8.3984375
▁measures 2.439453125
. 2.55859375
▁It 1.998046875
▁evaluated 4.41796875
▁the 0.58740234375
▁inter 5.51171875
dep 3.46875
end 0.0005192756652832031
ence 0.013641357421875
▁of 0.5029296875
▁various 3.642578125
▁factors 1.3681640625
▁that 2.728515625
▁affected 3.958984375
▁the 0.53759765625
▁physical 6.93359375
▁and 0.609375
▁emot 1.08984375
ional 0.0005693435668945312
▁condition 1.1484375
▁of 0.081787109375
▁patients 0.69970703125
▁experien 5.84375
cing 2.8967857360839844e-05
▁chron 0.441650390625
ic 0.0004794597625732422
▁pain 0.0267181396484375
. 0.289306640625
▁For 2.666015625
▁example 0.36328125
, 0.0094146728515625
▁the 1.408203125
▁survey 6.0703125
▁showed 4.48046875
▁that 0.77001953125
▁the 1.4130859375
▁ratio 6.6484375
▁of 0.11871337890625
▁female 4.46875
▁patients 0.8955078125
▁was 1.921875
▁remark 9.875
ably 0.00040149688720703125
▁higher 0.490234375
▁in 3.044921875
▁the 1.9423828125
▁op 4.82421875
i 3.505859375
ates 0.062164306640625
▁group 0.384521484375
▁compared 2.369140625
▁to 0.15966796875
▁the 0.26220703125
▁MM 1.0341796875
▁group 0.5947265625
. 0.2474365234375
▁In 2.8203125
▁turn 5.01171875
, 0.002838134765625
▁people 5.54296875
▁on 6.05078125
▁op 1.4150390625
i 0.32666015625
ates 0.0014467239379882812
▁were 1.1376953125
▁more 1.09375
▁likely 0.38671875
▁to 0.054962158203125
▁report 2.732421875
▁major 6.21484375
▁de 0.3828125
press 1.2607421875
ive 0.00545501708984375
▁dis 0.5888671875
orders 1.2353515625
. 1.890625
<0x0A> 2.306640625
Part 4.69921875
icip 0.055023193359375
ants 0.0308074951171875
▁were 0.76708984375
▁rec 0.51611328125
ru 0.0009298324584960938
ited 3.993511199951172e-05
▁for 0.48388671875
▁six 0.49560546875
▁months 0.0093994140625
▁at 0.1968994140625
▁two 0.03826904296875
▁major 0.16455078125
▁pain 0.018951416015625
▁relief 0.020477294921875
▁cent 0.156982421875
ers 0.0091400146484375
▁in 0.0986328125
▁Israel 0.0369873046875
. 0.1422119140625
▁All 4.234375
▁patients 1.3955078125
▁experienced 5.296875
▁chron 2.251953125
ic 0.0008797645568847656
▁pain 0.0714111328125
▁for 3.287109375
▁at 0.62939453125
▁least 0.00096893310546875
▁ 1.8857421875
3 1.54296875
▁months 0.281005859375
. 0.88623046875
▁The 1.1796875
▁study 1.935546875
▁included 2.376953125
▁ 1.9296875
8 2.958984375
9 2.841796875
0 3.67578125
▁participants 1.462890625
, 1.5263671875
▁of 1.9580078125
▁which 0.41015625
▁ 0.167724609375
4 1.2939453125
7 2.494140625
4 2.69921875
▁( 2.341796875
5 0.08612060546875
9 11.1953125
%) 0.7978515625
▁were 0.498291015625
▁treated 4.0625
▁sole 6.91796875
ly 9.942054748535156e-05
▁with 0.3427734375
▁op 0.56494140625
io 1.8916015625
ids 0.298583984375
, 1.2822265625
▁ 0.7421875
3 0.9833984375
2 1.9697265625
9 2.634765625
▁( 0.055145263671875
4 1.0126953125
1 1.1748046875
%) 0.10528564453125
▁were 1.322265625
▁treated 0.41015625
▁with 0.30078125
▁MM 1.45703125
, 0.4990234375
▁and 0.135498046875
▁ 0.2198486328125
7 2.990234375
7 2.44921875
▁( 0.16015625
8 3.69140625
. 1.2841796875
6 3.150390625
%) 0.042633056640625
▁acquired 10.4375
▁both 1.35546875
▁( 6.65234375
Fe 9.3671875
ing 3.97265625
old 0.0149688720703125
▁et 1.8974609375
▁al 0.027191162109375
., 0.293212890625
▁ 0.01195526123046875
2 0.278076171875
0 0.001598358154296875
1 0.48388671875
7 2.197265625
). 0.1097412109375
▁The 1.2021484375
▁remaining 6.51953125
▁ten 7.4140625
▁participants 1.3955078125
▁who 5.5703125
▁did 1.3046875
▁not 0.00640106201171875
▁receive 2.22265625
▁ph 3.361328125
arma 0.08087158203125
ce 0.0018329620361328125
ut 1.1086463928222656e-05
ical 0.00390625
▁op 0.7529296875
io 0.1104736328125
ids 0.0313720703125
▁and 1.74609375
▁medical 2.138671875
▁mar 0.033447265625
iju 0.003696441650390625
ana 0.0003609657287597656
▁were 1.35546875
▁with 6.89453125
dra 0.0550537109375
wn 0.00012087821960449219
▁from 0.26123046875
▁the 0.1015625
▁analysis 4.5234375
▁in 4.84765625
▁the 1.3134765625
▁research 4.4453125
. 0.54345703125
▁Therefore 4.86328125
, 0.007503509521484375
▁it 3.185546875
▁is 1.2041015625
▁not 3.04296875
▁possible 0.865234375
▁to 0.0173187255859375
▁compreh 6.921875
ens 0.144287109375
ively 0.007076263427734375
▁compare 2.02734375
▁patients 4.59375
▁taking 4.78125
▁medic 3.84765625
ations 0.47265625
▁with 0.92578125
▁those 2.478515625
▁who 1.1337890625
▁do 1.8427734375
▁not 0.0081024169921875
. 0.8271484375
<0x0A> 0.72021484375
Am 6.921875
ong 0.01202392578125
▁all 2.45703125
▁participants 1.25
▁in 3.416015625
▁the 0.154296875
▁study 0.38134765625
, 0.0755615234375
▁ 0.6572265625
4 1.9228515625
2 2.361328125
. 1.8798828125
2 2.279296875
% 0.09527587890625
▁suffered 4.96484375
▁from 0.07769775390625
▁de 1.2294921875
pression 0.115478515625
, 1.001953125
▁and 1.466796875
▁ 0.1182861328125
3 1.53515625
7 2.185546875
% 2.712890625
▁experienced 2.7578125
▁excess 7.9140625
ive 0.0966796875
▁anx 0.1962890625
iety 0.001392364501953125
. 0.38037109375
▁The 1.412109375
▁pl 11.359375
ur 0.98291015625
ality 0.0002034902572631836
▁of 0.1864013671875
▁de 3.494140625
press 1.361328125
ive 0.043365478515625
▁dis 1.8876953125
orders 0.05914306640625
▁among 3.609375
▁patients 1.2626953125
▁in 3.501953125
▁the 0.2474365234375
▁op 1.765625
i 1.3984375
ates 0.0032253265380859375
, 7.21875
▁medical 3.365234375
▁mar 0.02642822265625
iju 0.005096435546875
ana 3.516674041748047e-05
, 0.1834716796875
▁and 0.0567626953125
▁mixed 6.66015625
▁OP 8.53125
MM 6.71875
▁groups 0.63134765625
▁number 7.80078125
ed 0.00878143310546875
▁ 0.09783935546875
5 2.0859375
7 2.478515625
. 0.2259521484375
1 2.400390625
%, 0.3193359375
▁ 0.005706787109375
2 3.40234375
2 2.544921875
. 0.10992431640625
3 2.220703125
%, 0.131591796875
▁and 0.0236358642578125
▁ 0.002666473388671875
5 3.13671875
1 2.3984375
. 0.1746826171875
4 2.142578125
%, 0.36572265625
▁respectively 0.00995635986328125
. 0.328857421875
▁The 1.474609375
▁pl 4.3828125
ur 0.0289764404296875
ality 2.872943878173828e-05
▁of 0.04486083984375
▁anx 1.0009765625
iety 0.00975799560546875
▁contained 11.296875
▁ 0.52734375
4 1.619140625
8 2.412109375
. 0.06304931640625
4 2.306640625
% 0.58984375
▁among 1.525390625
▁OP 6.7578125
▁patients 8.8828125
, 0.3310546875
▁ 0.11474609375
2 1.443359375
1 2.41796875
. 0.1324462890625
5 2.357421875
% 0.01145172119140625
▁among 0.3740234375
▁MM 0.4091796875
▁patients 0.21533203125
, 0.0170745849609375
▁and 0.0119781494140625
▁ 0.034576416015625
3 1.146484375
8 2.60546875
. 0.1583251953125
7 2.271484375
% 0.01548004150390625
▁among 0.216552734375
▁OP 4.39453125
MM 0.2296142578125
▁participants 2.96875
. 0.2763671875
▁Pat 5.66796875
ients 0.0223236083984375
▁who 2.267578125
▁took 2.9140625
▁strong 8.171875
▁op 0.9658203125
i 1.662109375
ates 0.0034885406494140625
▁were 1.853515625
▁t 9.25
ended 1.447265625
▁to 0.0257720947265625
▁place 10.3515625
▁their 3.365234375
▁pain 2.861328125
▁on 3.3203125
▁a 1.005859375
▁scale 2.474609375
▁of 0.48193359375
▁ 0.362060546875
9 3.142578125
▁to 1.3427734375
▁ 0.016448974609375
1 0.0343017578125
0 0.07037353515625
▁( 2.396484375
Fe 1.58984375
ing 0.012725830078125
old 0.0007123947143554688
▁et 0.0634765625
▁al 0.0014705657958984375
., 0.0225677490234375
▁ 0.002185821533203125
2 0.0008196830749511719
0 0.0001291036605834961
1 0.0026493072509765625
7 0.02362060546875
). 0.051422119140625
▁They 4.59765625
▁were 1.2158203125
▁also 1.6416015625
▁an 8.7265625
gu 4.9296875
ished 0.037200927734375
▁em 9.015625
otion 0.01187896728515625
ally 0.00315093994140625
▁and 1.3359375
▁react 7.48046875
ed 0.0599365234375
▁rad 9.8203125
ically 0.0027942657470703125
▁neg 5.79296875
atively 0.00090789794921875
▁to 0.330078125
▁almost 5.921875
▁all 0.97998046875
▁survey 8.9140625
▁questions 1.166015625
. 0.349365234375
▁Pat 4.09765625
ients 0.00920867919921875
▁who 1.1591796875
▁took 1.5615234375
▁only 5.63671875
▁MM 1.1640625
▁or 3.447265625
▁mixed 3.2265625
▁medic 2.92578125
ations 0.379638671875
▁course 12.109375
▁had 2.5390625
▁a 1.177734375
▁significantly 2.744140625
▁more 4.04296875
▁stable 3.978515625
▁emot 1.3486328125
ional 0.00940704345703125
▁state 0.9228515625
▁and 1.66796875
▁cop 5.3359375
ed 0.7177734375
▁with 0.7509765625
▁pain 1.5166015625
▁more 1.625
▁manage 6.93359375
able 2.537109375
. 0.62158203125
<0x0A> 0.70068359375
The 1.2470703125
▁analysis 4.8125
▁of 0.560546875
▁any 8.9140625
▁human 7.94921875
▁reaction 4.77734375
▁has 5.078125
▁a 2.314453125
▁high 4.2890625
▁potential 3.005859375
▁of 1.7353515625
▁subject 6.19921875
iveness 3.833984375
▁and 1.484375
▁bias 2.646484375
, 2.205078125
▁especially 2.123046875
▁regarding 4.40234375
▁people 4.35546875
▁in 4.125
▁severe 4.1328125
▁pain 0.54150390625
▁and 2.8515625
▁un 5.25
stable 1.9326171875
▁emot 0.477294921875
ional 0.348876953125
▁condition 2.43359375
. 0.1092529296875
▁Perhaps 8.1953125
▁some 5.265625
▁patients 1.6796875
▁tend 5.609375
▁to 0.0251007080078125
▁ex 2.73046875
agger 0.003231048583984375
ate 0.00870513916015625
▁their 0.7041015625
▁de 4.55078125
press 1.09375
ive 0.1365966796875
▁state 2.82421875
▁or 2.056640625
▁vice 7.5625
▁vers 0.033050537109375
a 7.677078247070312e-05
, 1.2734375
▁de 7.63671875
- 4.64453125
emph 1.15625
as 0.0063323974609375
ize 0.1812744140625
▁serious 6.9296875
▁difficulties 6.07421875
. 1.0048828125
▁Because 6.04296875
▁the 1.9140625
▁survey 4.26171875
▁responses 8.2890625
▁were 1.08984375
▁thoroughly 7.765625
▁anonymous 4.88671875
, 0.48193359375
▁the 1.751953125
▁research 1.4677734375
ers 0.51953125
▁were 1.3828125
▁unable 1.8603515625
▁to 0.0035152435302734375
▁carefully 8.015625
▁analyze 1.515625
▁each 4.0390625
▁patient 1.546875
’ 27.53125
s 0.2802734375
▁reaction 3.7421875
▁and 2.46484375
▁compare 3.34375
▁it 1.0849609375
▁to 1.3095703125
▁the 0.82666015625
▁actual 5.34375
▁states 7.0
▁of 0.498046875
▁condition 7.98046875
. 0.4794921875
▁More 6.7578125
▁accurate 3.775390625
▁answers 4.62109375
▁could 2.369140625
▁be 0.99169921875
▁obtained 1.1865234375
▁by 1.283203125
▁professional 7.98828125
▁psych 2.2421875
olog 0.4599609375
ists 0.0017576217651367188
▁via 7.98828125
▁personal 4.7109375
▁communication 4.328125
▁and 1.8095703125
▁behavior 6.4140625
al 0.31494140625
▁analysis 2.349609375
. 0.3125
▁However 2.939453125
, 0.0017633438110351562
▁this 2.37890625
▁method 3.607421875
▁of 2.830078125
▁research 1.7607421875
▁is 1.2861328125
▁way 8.03125
▁more 1.9228515625
▁resource 6.0703125
- 0.6435546875
int 0.58349609375
ensive 0.00909423828125
▁and 0.66259765625
▁energy 8.8984375
- 0.143798828125
consum 0.33154296875
ing 0.0017461776733398438
. 0.77099609375
<0x0A> 0.83544921875
One 4.67578125
▁of 0.489013671875
▁the 0.0201263427734375
▁major 2.4453125
▁limitations 1.83984375
▁is 3.28515625
▁the 0.53125
▁ins 4.625
u 0.0221099853515625
fficient 0.1826171875
ly 4.57421875
▁high 2.92578125
▁response 3.326171875
▁rate 0.11199951171875
, 2.79296875
▁ 4.5625
5 1.9677734375
7 2.146484375
% 2.02734375
▁instead 6.921875
▁of 0.00618743896484375
▁ 0.65869140625
7 1.65625
0 1.39453125
% 1.0302734375
▁( 1.7802734375
Fe 0.28076171875
ing 0.00441741943359375
old 0.00038814544677734375
▁et 0.01439666748046875
▁al 0.001094818115234375
., 0.00728607177734375
▁ 0.0016660690307617188
2 0.0005140304565429688
0 0.00029349327087402344
1 0.001338958740234375
7 0.00795745849609375
). 0.03729248046875
▁It 2.376953125
▁can 3.357421875
▁be 0.427490234375
▁fairly 8.359375
▁explained 1.083984375
▁by 0.1685791015625
▁the 0.3408203125
▁weak 8.140625
▁focus 7.23828125
▁of 0.413330078125
▁respond 6.9453125
ents 0.12890625
▁who 3.638671875
▁have 4.05078125
▁overcome 7.75390625
▁severe 2.150390625
▁pain 0.5390625
▁sens 8.9921875
ations 1.2392578125
▁and 1.1318359375
▁de 3.916015625
press 1.705078125
ive 0.19970703125
▁episodes 4.15625
. 0.5634765625
▁It 3.28515625
▁is 0.86181640625
▁not 2.736328125
▁clear 3.95703125
▁how 1.705078125
▁to 3.6484375
▁use 5.5625
▁these 3.328125
▁statistics 3.5234375
, 2.57421875
▁as 1.466796875
▁they 1.4775390625
▁still 5.53515625
▁may 4.51953125
▁be 1.33203125
▁relevant 5.2265625
▁for 1.375
▁the 1.8515625
▁overall 4.375
▁analysis 2.96484375
. 1.0732421875
